4//SEC Filing
Kuriakose Emil 4
Accession 0001562180-25-002920
CIK 0001831363other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 6:48 PM ET
Size
5.6 KB
Accession
0001562180-25-002920
Insider Transaction Report
Form 4
Kuriakose Emil
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-04-01$2.49/sh−952$2,366→ 53,317 total
Footnotes (2)
- [F1]Represents shares of common stock sold to satisfy taxes associated with the vesting of a restricted stock unit award previously granted to the Reporting Person. Such sales do not represent a discretionary trade by the Reporting Person.
- [F2]This sale price represents the weighted average sale price of the shares sold ranging from $2.475 to $2.54 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Terns Pharmaceuticals, Inc.
CIK 0001831363
Entity typeother
Related Parties
1- filerCIK 0001892413
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 6:48 PM ET
- Size
- 5.6 KB